Case Name (Date)

Sherwood et al. v. Chattem, Inc.
23-cv-3980, S.D.N.Y.
(May 2023)


Product/Service

Cortizone-10 hydrocortisone topical creams, ointments, gels, lotions, and liquids


Allegations

Misleadingly marketing 1% hydrocortisone products as “Maximum Strength” when there are products with stronger dosages available


Status

Pending



Class-Action Tracker

Cortizone-10

Class Action

Cortizone-10

Allegations: Falsely marketing products with 1% hydrocortisone as “maximum strength”

ACT Dry Mouth Lozenges

Class Action

ACT Dry Mouth Lozenges

Allegations: Failing to disclose that the product is detrimental to oral health due to having a pH level that is below the pH level of tooth enamel and root dentin


The Latest

Filters

Aspercreme

Ad Alert

Aspercreme

TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.

Nasacort

Ad Alert

Nasacort

Makers of nasal allergy spray told to cease consumer preference claims.